TMED Institutional Ownership & Shareholders
T ROWE PRICE HEALTH CARE ETF (TMED) is currently held by 5 institutional investors tracked by InsiderSet, with a combined reported market value of approximately $3.87M based on the latest available SEC Form 13F filings for the quarter ended September 30, 2026.
Mowery & Schoenfeld Wealth Management, Llc is currently the largest disclosed institutional shareholder of TMED tracked by InsiderSet, reporting ownership valued at approximately $2.19M in its September 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $2.22M, representing an estimated gain of +1.17% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 100% of the total disclosed TMED value among the investors covered in this analysis. Major shareholders include Mowery & Schoenfeld Wealth Management, Llc, Flow Traders U.S. Llc, Commonwealth Equity Services, Llc, and several other long-term asset managers with concentrated positions in T ROWE PRICE HEALTH CARE ETF (TMED).
This page ranks the largest institutional TMED shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
5
Total Reported Value
$3.87M
Largest Holder
Mowery & Schoenfeld Wealth Management, Llc
Largest Position
$2.19M
Insider Transactions (90d)
0
Latest Filing Quarter
Q3 2026
New Institutional Positions
6
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Mowery & Schoenfeld Wealth Management, Llc | 2.45% | 64,671 | $2,194,954 | $2,220,608 | +$25,654 | +1.17% | |
| Flow Traders U.S. Llc | 0.03% | 23,827 | $814,000 | $818,148 | +$4,148 | +0.51% | |
| Commonwealth Equity Services, Llc | 0.00% | 10,171 | $345,210 | $349,242 | +$4,032 | +1.17% | |
| Essex Financial Services, Inc. | 0.02% | 9,100 | $310,790 | $312,467 | +$1,677 | +0.54% | |
| Citadel Advisors Llc | 0.00% | 5,958 | $203,482 | $204,580 | +$1,098 | +0.54% |
Frequently asked questions about TMED
Who are the largest institutional holders of TMED?
The largest institutional holders of TMED reported in the latest SEC Form 13F filings include Mowery & Schoenfeld Wealth Management, Llc, Flow Traders U.S. Llc, Commonwealth Equity Services, Llc, Essex Financial Services, Inc., and Citadel Advisors Llc. InsiderSet ranks institutional holders by their latest reported TMED position.
What is TMED institutional ownership?
This page tracks TMED positions reported by institutional investment managers through SEC Form 13F. T ROWE PRICE HEALTH CARE ETF (TMED) institutional ownership on InsiderSet reflects disclosed 13F holdings among the managers we analyze, not every shareholder of the stock.
How many institutions own TMED?
InsiderSet currently tracks 5 institutional managers reporting TMED holdings in the latest available 13F data. This count reflects institutions included in the SEC Form 13F filings analyzed by InsiderSet and should not be interpreted as the total number of TMED shareholders.
How much TMED stock do institutions own?
Institutional investment managers disclosed approximately $3.87M in TMED holdings for Q3 2026. This figure is reported 13F value as of the filing period, not necessarily today's market value.
When was TMED institutional ownership last updated?
The latest TMED institutional ownership data on InsiderSet is based on SEC Form 13F filings for the quarter ended September 30, 2026. Form 13F filings are generally reported after the quarter ends, so the holdings shown represent the latest publicly disclosed positions rather than real-time institutional holdings.
Are institutional TMED holdings real-time?
No. Form 13F data is not real-time. It represents positions reported by institutional investment managers as of the end of the reporting quarter. An institution may have changed its TMED position after the reporting date.
Are institutions buying or selling TMED?
Institutional buying and selling can be analyzed by comparing TMED positions across consecutive 13F reporting periods. InsiderSet's TMED Ownership Changes page shows institutions that increased, reduced, initiated, or exited positions based on reported 13F holdings. View TMED ownership changes.
How has TMED institutional ownership changed over time?
InsiderSet tracks TMED institutional holdings across multiple 13F reporting periods, allowing investors to compare institutional holder counts, reported value, and reported shares over time.